Unlocking the Power of Real-World Evidence with Federated Data Networks
In today’s rapidly evolving healthcare landscape, data is the linchpin for impactful decision-making. Particularly, Real-World Data (RWD) — data derived from everyday healthcare experiences like electronic health records (EHRs), insurance claims, disease registries, wearable devices and even social determinants of health — is reshaping how healthcare systems tackle known and emerging health problems. Real-World Evidence (RWE), the analysis of these diverse, real-world data streams, offers crucial insights into disease progression, drug safety and comparative effectiveness, treatment outcomes and patient experiences — helping to bridge gaps in clinical research and inform policy, drug development and public health readiness.
But accessing and leveraging this data isn’t without its challenges. Healthcare data is often siloed within different institutions, systems or geographical regions. Sharing sensitive patient data while ensuring security, privacy and compliance with regulations such as HIPAA or GDPR remains a persistent hurdle. Meanwhile, insights demand scale, diversity and inclusivity in datasets to ensure representation across different populations — a feat that’s often difficult to achieve with centralized approaches.
Enter federated data networks, a transformative solution that redefines how we access and analyze real-world data. Harmonizing patient data sets utilizing a Common Data Model (CDM) like the Observational Medical Outcomes Partnership (OMOP) — the standard data model designed and maintained by the Observational Health Data Sciences and Informatics (OHDSI) community — federated networks allow disparate organizations, including hospitals, research centers, insurance companies and other stakeholders, to collaborate on shared analyses without transferring or centralizing sensitive patient information. Instead of pooling data together, a federated model enables distributed data analytics — here algorithms travel to local databases, perform computations on-site and return aggregated results without sharing or exposing individual patient records.
This approach unlocks the full potential of RWE, offering access to extremely diverse datasets while maintaining patient privacy and building trust among data collaborators. For example, federated data networks can include datasets from rural hospitals, urban clinics and international providers, giving researchers and policymakers richer insights into how treatments work across different demographics, lifestyles and health systems. Moreover, federated models scale seamlessly, empowering organizations to include new data sources without overhauling existing infrastructure or compromising compliance.
The use of federated data networks is particularly critical in addressing emerging health challenges, such as global pandemics, rare diseases and precision medicine. During the COVID-19 pandemic, we saw firsthand how access to real-world data could accelerate vaccine development, map disease spread and inform policy interventions. Federated models extend this capability, enabling analysis of international datasets on new variants, treatment outcomes or vaccine efficacy, all without risking patient privacy breaches.
With the growing importance of personalized medicine, federated systems allow researchers to analyze genetic, environmental and lifestyle data at scale to customize treatment strategies for individual patients or subpopulations. They enable deeper understanding of health disparities, ensuring robust evidence that guides equitable interventions across differing socioeconomic or racial groups.
Real-world evidence, boosted by federated data networks, is measurably transforming healthcare into a more connected, informed and patient-centered domain. Enabling diverse institutions to collaborate securely and efficiently, federated models break down barriers, opening the door to innovative solutions for tackling both longstanding and emerging health challenges. As healthcare stakeholders continue to harness these technologies, the future of medicine looks brighter, with data taking center stage in solving the world’s most pressing health problems.
Strengthened by the acquisition of Odysseus Data Services, EPAM is proud to offer RWE solutions, services and education to its Life Sciences and Healthcare customers, from standardized data analytics and large-scale evidence generation to data standardization (OMOP, FHIR, SDTM) and bespoke RWE software engineering — including its flagship federated data network platform, Prometheus.
